Webinar | Nestlé and Arla are leading GLP-1 food innovation. Is your R&D keeping up?​ Register Now

Iscaffpharma

Iscaffpharma develops treatments for aggressive cancers using scaffold technology and a deep understanding of tumor microenvironments.
2018
1-10
Gothenburg, Vastra Gotaland, Sweden
  • Drug Discovery and Development
  • Oncology (Cancer)
  • Personalized Medicine Technologies

Investment Funding

Revenue

$1M to $10M

Something missing or incorrect on this page? Help us enrich this information